Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Eur J Vasc Endovasc Surg ; 44(1): 45-50, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22578564

ABSTRACT

OBJECTIVES: The NHS Abdominal Aortic Aneurysm Screening Programme (NAAASP), based on the Multicentre Aneurysm Screening Study (MASS) trial (2002), is being introduced across the UK. Recent studies have demonstrated a decline in prevalence of abdominal aortic aneurysm (AAA). The aim of this study was to examine the effect of this on screening workload. METHODS: A model was developed to predict screening and surgical workload for a screening centre (Bristol - population 1,123,203). Workload was compared using data from MASS with data from the "Early Implementers" (EI) of NAAASP. RESULTS: Modelling for 2011/2012 using EI data predicted significantly fewer men diagnosed with an AAA compared to MASS data [84 (EI) versus 198 (MASS) p < 0.0001] and fewer referrals to a vascular surgeon for AAA repair [10 (EI) versus 30 (MASS) p = 0.0002). This difference became more marked with time (2015/16: 90 (EI) versus 212 (MASS) men diagnosed with an AAA (p < 0.0001) and 29 (EI) versus 71 (MASS) referred to a vascular surgeon (p < 0.0001)). From 2015/16 there was also a significant reduction in the predicted number of ultrasound scans. CONCLUSIONS: Modelling screening activity based on contemporary epidemiological data demonstrates a significant reduction in workload compared to MASS data. This has implications for workforce planning, the introduction of new screening centres and the future of NAAASP.


Subject(s)
Aortic Aneurysm, Abdominal/epidemiology , Mass Screening , Vascular Surgical Procedures/statistics & numerical data , Workload/statistics & numerical data , Aged , Aortic Aneurysm, Abdominal/diagnosis , Aortic Aneurysm, Abdominal/surgery , Humans , Male , Prevalence , Reproducibility of Results , United Kingdom/epidemiology , Vascular Surgical Procedures/trends
2.
Eur J Vasc Endovasc Surg ; 38(2): 213-9, 2009 Aug.
Article in English | MEDLINE | ID: mdl-19464204

ABSTRACT

OBJECTIVES: To determine the effect of altering written advice on return to activities following varicose vein surgery. METHODS: During two consecutive four-month periods, 134 patients (84 female, median age 57 years) were given two different information booklets. The first booklet (76 patients) suggested 7-10 days before driving and 2-3 weeks before returning to work. The second booklet (58 patients) explicitly advised return to all activities as soon as possible. Patients were contacted 6 weeks following surgery. Advice was sought from motor insurance companies about their views on return to driving. RESULTS: There was huge variation in time to driving (0-35 days, median 7), work (1-45 days, median 14) and "all normal activities" (1-62 days, median 21), but no significant differences between the two groups. There were paradoxes in the delays to driving and different types of work. Delays to driving or work were longer after bilateral surgery (p=0.01). CONCLUSION: Changing written advice did not influence the time to return to activities following varicose vein surgery, which was highly variable. Other factors may influence recovery and may be challenging for specialists to change. Consistent advice is important when comparing recovery from different treatments.


Subject(s)
Activities of Daily Living , Automobile Driving , Health Knowledge, Attitudes, Practice , Pamphlets , Patient Education as Topic , Sick Leave , Varicose Veins/surgery , Vascular Surgical Procedures , Female , Humans , Male , Middle Aged , Recovery of Function , Time Factors , Treatment Outcome
3.
Phlebology ; 24 Suppl 1: 50-61, 2009.
Article in English | MEDLINE | ID: mdl-19307441

ABSTRACT

OBJECTIVE: Endovenous laser ablation (EVLA) of incompetent truncal veins has been proposed as a minimally invasive alternative to conventional surgery for varicose veins. Various strategies have been proposed for successful treatment and this study reviews the evidence for these. METHOD: A Medline and 'controlled trials online database' search was performed to identify original articles and randomized controlled trials (RCTs) reporting outcomes for EVLA. Information on patient selection, equipment, technique and outcomes were recorded. RESULTS: Ninety-eight original studies, including five RCTs, were identified. RCT data indicate short-term outcomes (abolition of reflux, improvement in quality of life [QOL], patient satisfaction) were equivalent to those for surgery. Long-term follow-up is not available. A further RCT showed superior outcomes for ablation commencing at the lowest point of superficial venous reflux rather than at an arbitrary point (fewer residual varicosities, greater improvement in QOL). Non-randomized series suggest that laser energy of >60 J/cm results in reliable truncal vein occlusion and that longer wavelength lasers may be associated with less post-treatment discomfort. CONCLUSION: In the short-term EVLA is a safe and effective treatment for patients with varicose veins. Long-term follow-up is still required.


Subject(s)
Laser Therapy , Saphenous Vein/surgery , Varicose Veins/surgery , Vascular Surgical Procedures , Cost-Benefit Analysis , Delivery of Health Care , Evidence-Based Medicine , Health Care Costs , Humans , Laser Therapy/adverse effects , Laser Therapy/economics , Quality of Life , Treatment Outcome , Vascular Surgical Procedures/adverse effects , Vascular Surgical Procedures/economics
4.
Eur J Vasc Endovasc Surg ; 37(4): 477-81, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19201621

ABSTRACT

AIM: During surgery for sapheno-femoral junction (SFJ) and anterior accessory great saphenous vein (AAGSV) reflux, many surgeons also strip the great saphenous vein (GSV). This study assesses the short-term efficacy (abolition of reflux on Duplex ultrasound) of endovenous laser ablation (EVLA) of the AAGSV with preservation of a competent GSV in the treatment of varicose veins occurring due to isolated AAGSV incompetence. METHOD: Thirty-three patients (21 women and 12 men) undergoing AAGSV EVLA alone (group A) and 33 age/sex-matched controls undergoing GSV EVLA (Group B) were studied. Comparisons included ultrasound assessment of SFJ competence, successful axial vein ablation, Aberdeen Varicose Vein Symptom Severity Scores (AVVSS) and a visual analogue patient-satisfaction scale. RESULTS: At the 1-year follow-up, EVLA had successfully abolished the target vein reflux (AAGSV: median length 19 cm (inter-quartile range, IQR: 14-24 cm) vs. GSV: 32 cm (IQR 24-42 cm)) and had restored SFJ competence in all patients. Twenty of the 33 patients (61%) in group A and 14 of the 33 (42%) in group B (p=0.218) required post-ablation sclerotherapy at 6 weeks post-procedure for residual varicosities. The AVVSS at 12 months follow-up had improved from the pre-treatment scores in both the groups (group A: median score 4.1 (IQR 2.1-5.2) vs. 11.6 (IQR: 6.9-15.1) p<0.001; group B: median score 3.3 (IQR 1.1-4.5) vs. 14.5 (IQR 7.6-20.2), p<0.001), with no significant difference between the groups. Patient-satisfaction scores were similar (group A: 84% and group B: 90%). Previous intervention in group A included GSV EVLA (n=3) or stripping (n=9). Thus, the GSV was preserved in 21 patients. The AVVSS also improved in this subgroup (4.4 (2.0-5.4) vs. 11.4 (6.0-14.1), p<0.001) and SFJ/GSV competence was found to be restored at the 1-year follow-up. CONCLUSIONS: AAGSV EVLA abolishes SFJ reflux, improves symptom scores and is, therefore, suitable for treating varicose veins associated with AAGSV reflux.


Subject(s)
Femoral Vein/surgery , Laser Therapy , Saphenous Vein/surgery , Varicose Veins/surgery , Adult , Aged , Case-Control Studies , Female , Femoral Vein/diagnostic imaging , Femoral Vein/physiopathology , Follow-Up Studies , Humans , Male , Middle Aged , Patient Satisfaction , Regional Blood Flow/physiology , Saphenous Vein/diagnostic imaging , Saphenous Vein/physiopathology , Sclerotherapy , Ultrasonography , Varicose Veins/diagnostic imaging , Varicose Veins/physiopathology , Vascular Patency
5.
Phlebology ; 24(1): 17-20, 2009 Feb.
Article in English | MEDLINE | ID: mdl-19155336

ABSTRACT

AIMS: The standard technique for endovenous laser ablation (EVLA) for varicose veins due to great saphenous vein (GSV) reflux involves obliteration of the above-knee (AK) GSV. This study assesses the significance of persistent below-knee (BK) GSV reflux following such therapy. METHODS: Sixty-nine limbs (64 patients) with varicosities and GSV reflux underwent AK-EVLA. Post treatment, GSV reflux (ultrasound: six, 12 weeks) and Aberdeen varicose vein severity scores (AVVSS, 12 weeks) were assessed, and residual varicosities treated with foam sclerotherapy (six weeks). RESULTS: The untreated BK-GSV remained patent in all limbs. Ultrasound showed normal antegrade flow in 34/69 (49%, Group A), flash reflux<1 s in 7/69 (10%, Group B) and >1 s reflux in 28/69 (41%, Group C). Although AVVSS improved in all groups (P<0.001): A: 14.6 (8.4-19.3) versus 2.8 (0.5-4.4), B: 13.9 (7.5-20.1) versus 3.7 (2.1-6.8), C: 15.1 (8.9-22.5) versus 8.1 (5.3-12.6) the improvement was less in Group C (P<0.001 versus A and B) and was associated with a greater requirement (A: 4/34 [12%]; B: 1/7 [14%]; C: 25/28 [89%]) for sclerotherapy (persisting varicosities) (P<0.001). CONCLUSION: Although AK-GSV EVLA improves symptoms regardless of persisting BK reflux, the latter appears responsible for residual symptoms and a greater need for sclerotherapy for residual varicosities.


Subject(s)
Laser Therapy , Postoperative Complications/therapy , Saphenous Vein/surgery , Varicose Veins/surgery , Venous Insufficiency/therapy , Adult , Female , Follow-Up Studies , Humans , Knee , Male , Middle Aged , Postoperative Complications/diagnostic imaging , Regional Blood Flow , Saphenous Vein/diagnostic imaging , Sclerotherapy , Severity of Illness Index , Treatment Outcome , Ultrasonography , Varicose Veins/diagnostic imaging , Venous Insufficiency/diagnostic imaging
6.
Eur J Vasc Endovasc Surg ; 36(2): 211-215, 2008 Aug.
Article in English | MEDLINE | ID: mdl-18474444

ABSTRACT

OBJECTIVE: To assess changes in great saphenous vein (GSV) diameter and the significance of re-canalisation following endovenous laser ablation (EVLA). DESIGN: Prospective cohort study. METHODS: Two groups were studied. Group A: 73 consecutive patients (84 GSVs) underwent EVLA followed by duplex ultrasound at 6, 12 and 52 weeks. Vein diameter and patency were recorded. Group B: From a prospectively maintained database 27 patients with a GSV that was found to have recanalised 6-12 weeks post-EVLA were identified and rescanned at 52 weeks. Pre- and post-treatment Aberdeen varicose vein severity scores (AVVSS) were measured. RESULTS: Group A: 81/84 (96%) GSVs were ablated and 3/84 (4%) had re-canalised (flash reflux <1s). GSV diameter diminished with time: pre-EVLA: mean diameter 7.7 S.D .2.0mm; 6 weeks: 5.1 S.D. 1.3mm; 12 weeks: 3.2 S.D. 1.2; 52 weeks: 85% non-visible (p<0.001). Group B: 3/27 (11%) with reflux >1s underwent repeat EVLA. 16/27 (59%) remained competent at 52 weeks and 8/27 (30%) showed trickle reflux. Vein diameter decreased in both subgroups (mean diameter 7.3 S.D. 2.5mm to 3.1 S.D. 0.8mm (p=0.006) and 7.2 S.D. 2.3mm to 3.0 S.D. 0.7mm (p=0.009) respectively) as did the AVVSS (p<0.001). CONCLUSIONS: Successful EVLA causes GSV shrinkage with transition from a non-compressible "thrombosed" vein to a non-visible vein by 1 year. A re-canalised GSV usually remains small with no/minimal reflux and persisting clinical benefit.


Subject(s)
Laser Therapy , Saphenous Vein/surgery , Varicose Veins/surgery , Adult , Aged , Female , Humans , Male , Middle Aged , Prospective Studies , Recurrence , Reoperation , Saphenous Vein/diagnostic imaging , Severity of Illness Index , Time Factors , Treatment Failure , Ultrasonography, Doppler, Duplex , Varicose Veins/diagnostic imaging
7.
Br J Surg ; 95(7): 915-8, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18496889

ABSTRACT

BACKGROUND: Transanal endoscopic microsurgery (TEM) is a minimally invasive technique for the excision of rectal lesions, with lower morbidity and mortality rates than open surgery. Following advances in laparoscopic colorectal surgery and endoscopic mucosal resection, this study evaluated the safety and efficacy of TEM in the treatment of complex rectal lesions. METHODS: All patients were entered into a prospective database. Complex lesions were identified as high (more than 15 cm from anorectal margin), large (maximum dimension over 8 cm), involving two or more rectal quadrants, or recurrent. RESULTS: Seventy-one lesions (13 carcinomas and 58 tubulovillous adenomas) were identified. The median duration of operation was 60 (interquartile range (i.q.r.) 30-80) min, with an estimated median blood loss of 0 (i.q.r. 0-10) ml. Median hospital stay was 2 (i.q.r. 1-3) days. One patient developed postoperative urinary retention and one returned with rectal bleeding that did not require further surgery. Two patients developed rectal strictures after operation that were dilated successfully. There was no recurrence of benign lesions during a median follow-up of 21 (i.q.r. 6.5-35) months. CONCLUSION: TEM is a safe technique with low associated morbidity, even when used to excise complex rectal lesions. As such it remains the treatment of choice for rectal lesions not requiring primary radical resection.


Subject(s)
Adenoma, Villous/surgery , Carcinoma/surgery , Microsurgery/methods , Proctoscopy/methods , Rectal Neoplasms/surgery , Blood Loss, Surgical , Humans , Length of Stay , Postoperative Complications/etiology , Prospective Studies
8.
Colorectal Dis ; 10(6): 619-20, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18294273

ABSTRACT

INDICATIONS: The repair of high recto-vaginal fistula can be challenging since access may be limited via the endo-anal approach yet the alternative trans-abdominal route carries significant morbidity. We report the use of TEMS to repair a recto-vaginal fistula following anterior resection and pelvic radiotherapy. METHOD: The patient was placed prone and a 25 cm rectoscope was inserted. A proximally based mucosal advancement flap was raised to repair the fistula. The patient was discharged 2 days later and a contrast study confirmed closure of the fistula. COMPARISON WITH OTHER TECHNIQUES: TEMS allows excellent visualisation of a rectovaginal fistula compared to standard endo-anal or trans-vaginal techniques. The morbidity is lower than the trans-abdominal route. COMMENTS: TEMS is a useful technique for the repair of benign recto-vaginal fistula and has distinct advantages over conventional techniques.


Subject(s)
Endoscopy , Microsurgery/methods , Rectovaginal Fistula/surgery , Adenocarcinoma/surgery , Aged , Anal Canal , Female , Humans , Rectal Neoplasms/surgery
9.
Br J Surg ; 95(3): 294-301, 2008 Mar.
Article in English | MEDLINE | ID: mdl-18278775

ABSTRACT

BACKGROUND: Endovenous laser ablation (EVLA) is a minimally invasive technique for treating varicose veins due to truncal vein incompetence. This randomized trial compared EVLA with conventional surgery in patients with primary saphenofemoral and great saphenous vein (GSV) reflux. METHODS: Consecutive consenting patients with symptomatic varicose veins were randomized to EVLA 1 (stepwise laser withdrawal), EVLA 2 (continuous laser withdrawal) or surgery (saphenofemoral ligation, GSV stripping, multiple phlebectomies). Principal outcome measures were abolition of GSV reflux and improvement in Aberdeen Varicose Vein Symptom Score (AVVSS) 3 months after treatment. RESULTS: GSV reflux was abolished in 41 of 42 legs treated with EVLA 1, 26 of 29 following EVLA 2 and 28 of 32 after surgery (P = 0.227). The median (interquartile range, i.q.r.) AVVSS improvement was similar: 9.38 (4.54-14.93) with EVLA 1, 10.26 (5.03-15.03) after EVLA 2 and 8.36 (4.54-13.21) following surgery (P = 0.694). Return to normal activity (median (i.q.r.) 2 (0-7) versus 7 (2-26) days; P = 0.001) and work (4 (2-7) versus 17 (7.25-33.25) days; P = 0.005) was quicker after EVLA by either method. CONCLUSION: Abolition of reflux and improvement in disease-specific quality of life was comparable following both EVLA and surgery. The earlier return to normal activity following EVLA may confer important socioeconomic advantages. REGISTRATION NUMBER: ISRCTN99270116 (http://www.controlled-trials.com).


Subject(s)
Laser Therapy/methods , Saphenous Vein/surgery , Varicose Veins/surgery , Adult , Analgesics/therapeutic use , Endoscopy/methods , Female , Humans , Male , Middle Aged , Pain, Postoperative/etiology , Pain, Postoperative/prevention & control , Patient Satisfaction , Postoperative Complications/etiology , Severity of Illness Index , Treatment Outcome , Venous Insufficiency/surgery
SELECTION OF CITATIONS
SEARCH DETAIL
...